Ruiping Dong is the founder of Haihe Biopharma. Haihe Biopharma has raised $318M in total funding. Latest round: Series B. Based in Shanghai, China.
Ruiping Dong is the CEO of Haihe Biopharma, a biotech company focused on the discovery, development, and commercialization of innovative oncology drugs. She has led the company through significant financing rounds to advance its pipeline and expand its global footprint.
Full founder directory · Investor directory · Company funding database · Fundraising library